• BofA Securities has raised its price target on CVS Health to $110 from $100, maintaining a Buy rating.
  • The upgrade follows CVS Health's announcement of expanding its GLP-1 support programs across its pharmacy locations, MinuteClinic, and virtual platform.
  • These new offerings aim to provide lower-cost access, including a $50-per-month Medicare Bridge program and $49 virtual weight management services.